JP2025516714A5 - - Google Patents

Info

Publication number
JP2025516714A5
JP2025516714A5 JP2024567558A JP2024567558A JP2025516714A5 JP 2025516714 A5 JP2025516714 A5 JP 2025516714A5 JP 2024567558 A JP2024567558 A JP 2024567558A JP 2024567558 A JP2024567558 A JP 2024567558A JP 2025516714 A5 JP2025516714 A5 JP 2025516714A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
approximately
sirolimus
weeks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024567558A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516714A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066897 external-priority patent/WO2023220690A1/en
Publication of JP2025516714A publication Critical patent/JP2025516714A/ja
Publication of JP2025516714A5 publication Critical patent/JP2025516714A5/ja
Pending legal-status Critical Current

Links

JP2024567558A 2022-05-12 2023-05-11 Faslミクロゲルを用いた一過性シロリムス Pending JP2025516714A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263364607P 2022-05-12 2022-05-12
US63/364,607 2022-05-12
PCT/US2023/066897 WO2023220690A1 (en) 2022-05-12 2023-05-11 Transient sirolimus with fasl microgels

Publications (2)

Publication Number Publication Date
JP2025516714A JP2025516714A (ja) 2025-05-30
JP2025516714A5 true JP2025516714A5 (cg-RX-API-DMAC7.html) 2026-05-19

Family

ID=88731172

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024567558A Pending JP2025516714A (ja) 2022-05-12 2023-05-11 Faslミクロゲルを用いた一過性シロリムス

Country Status (6)

Country Link
US (1) US20250312321A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522236A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025516714A (cg-RX-API-DMAC7.html)
AU (1) AU2023268552A1 (cg-RX-API-DMAC7.html)
CA (1) CA3257338A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023220690A1 (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE064306T2 (hu) * 2017-03-10 2024-02-28 Univ Louisville Res Found Inc FasL-módosított bioanyagok immunmodulátor funkcióval
KR20200136974A (ko) * 2018-03-29 2020-12-08 브루노 라이케르트 심장, 신장, 폐 또는 간의 동소성 및 이소성 이종 이식 후 생존을 연장하기 위한 조성물

Similar Documents

Publication Publication Date Title
Squadrito et al. Pharmacological activity and clinical use of PDRN
KR101505202B1 (ko) 인간 배아 줄기 세포 및 그의 유도체를 포함하는 조성물, 그의 사용 방법 및 제조 방법
AU2010341000B2 (en) Combination preparations comprising a cytokine antagonist and corticosteroid
JP2023551877A5 (cg-RX-API-DMAC7.html)
US20260014085A1 (en) Milk derived exosomes and uses thereof
EP3626256B1 (fr) Composition pour le traitement des lésions tissulaires
MC1791A1 (fr) Association antivirale
JPH03503289A (ja) 膵臓炎及び膵臓移植組織中の免疫拒絶の治療に於けるs‐アデノシル‐メチオニン
JPH01502592A (ja) 白血病およびある種の悪性腫瘍の治療方法
CN100490820C (zh) 单独包含去纤苷酸或与其它抗肿瘤剂联合的抗肿瘤制剂
Cesar et al. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication
Gottipati et al. Delayed administration of interleukin-4 coacervate alleviates the neurotoxic phenotype of astrocytes and promotes functional recovery after a contusion spinal cord injury
Voltarelli et al. Stem cell therapies for type 1 diabetes mellitus
FR2713487A1 (fr) Solutions de type homéopathique contenant un acide nucléique utilisables notamment dans la prévention ou le traitement de maladies infectieuses ou de maladies impliquant le dysfonctionnement d'un gène.
US20040132698A1 (en) Androgen as a male contraceptive and non-contraceptive androgen replacement
Takedachi et al. Periodontal tissue regeneration by transplantation of autologous adipose tissue-derived multi-lineage progenitor cells with carbonate apatite
FR2466454A1 (fr) Peptides ayant des proprietes immunostimulantes et compositions pharmaceutiques les contenant
US20240374651A1 (en) Acellular Placental Therapies
CA2333776A1 (fr) Compositions a base de pentoxifylline et d'anticytokine
JPH0460093B2 (cg-RX-API-DMAC7.html)
CN105497017A (zh) 蟛蜞菊内酯的制药用途
HK1168753A (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
HK1168533A (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
HK1168755A (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
HK1124251A (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation